Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Leases (2019 - 2025)

Sunshine Biopharma (SBFM) has disclosed Current Leases for 5 consecutive years, with $218053.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 87.57% year-over-year to $218053.0, compared with a TTM value of $218053.0 through Sep 2025, up 87.57%, and an annual FY2024 reading of $207756.0, up 75.07% over the prior year.
  • Current Leases was $218053.0 for Q3 2025 at Sunshine Biopharma, down from $222496.0 in the prior quarter.
  • Across five years, Current Leases topped out at $222496.0 in Q2 2025 and bottomed at $114452.0 in Q2 2024.
  • Average Current Leases over 4 years is $150948.0, with a median of $121724.5 recorded in 2023.
  • The sharpest move saw Current Leases decreased 6.3% in 2024, then surged 94.4% in 2025.
  • Year by year, Current Leases stood at $123026.0 in 2022, then dropped by 3.54% to $118670.0 in 2023, then soared by 75.07% to $207756.0 in 2024, then rose by 4.96% to $218053.0 in 2025.
  • Business Quant data shows Current Leases for SBFM at $218053.0 in Q3 2025, $222496.0 in Q2 2025, and $213983.0 in Q1 2025.